Approval · Notice of Compliance 10430 · 2009
RAN-FENTANYL MATRIX PATCH: Notice of Compliance 10430
Issued July 22, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10430
- Date
- July 22, 2009
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- DURAGESIC (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-FENTANYL MATRIX PATCH | 02330105 | Cancelled Post Market |
| RAN-FENTANYL MATRIX PATCH | 02330113 | Cancelled Post Market |
| RAN-FENTANYL MATRIX PATCH | 02330121 | Cancelled Post Market |
| RAN-FENTANYL MATRIX PATCH | 02330148 | Cancelled Post Market |
| RAN-FENTANYL MATRIX PATCH | 02330156 | Cancelled Post Market |